What question did this study set out to answer?

To assess changes in the rates and numbers of newly identified cancer diagnoses before and during the COVID-19 pandemic in the United States.

August 4, 2020JAMA Network OpenOpen Access

Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

View Full Paper

Ask AI

Bookmark

Authors

HKHarvey W. KaufmanHarvard University ZCZhen ChenGuangzhou University of Chinese Medicine JNJustin K. NilesQuest Diagnostics (United States)

Discussion

Member takes

Implication

Observational study observes shifts in newly diagnosed cancer cases during the COVID-19 pandemic, indicating disruptions in routine cancer detection and screening.

Key Points

To assess changes in the rates and numbers of newly identified cancer diagnoses before and during the COVID-19 pandemic in the United States.
Comparative analysis tracking newly identified cancer diagnoses across baseline and COVID-19 pandemic periods.
Significant reductions occurred in newly identified cancer cases during the COVID-19 period compared to baseline across various tumor types, including pancreatic cancer.

Cite This Study

Kaufman et al. (2020) studied this question.

synapsesocial.com/papers/69eede2fa84321e0ae63c355 https://doi.org/10.1001/jamanetworkopen.2020.17267

View Full Paper

Ask AI

Bookmark

Implication

Observational study observes shifts in newly diagnosed cancer cases during the COVID-19 pandemic, indicating disruptions in routine cancer detection and screening.

Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

Discussion

Member takes

Implication

Key Points

Cite This Study

Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider